Overview

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2029-10-01
Target enrollment:
Participant gender:
Summary
This research study is for people who have head and neck cancer that has come back or spread to other places in the body.
Phase:
PHASE2
Details
Lead Sponsor:
SWOG Cancer Research Network
Collaborators:
Janssen Medical Affairs
SWOG Clinical Trials Partnerships, LLC